Investor
Aisling Capital
PE firm
Key details
- Profile type
- Organization
- Geography
- New York City, New York, USA
- Stage
- 4. Scaling, 5. Growth, 3. Early Revenue
- Sector
- health-tech, healthier living, metabolomics, CGT, drug, connected health, ehealth, CBD, life-science, life sciences tools, wellbeing, celle therapy, medicine, tech-enabled health, e-health, biomarkers, IVD, pharma, life science, wellness, biotech, healthtech, healthcare, drugs, life sciences, genomics, lifesciences, mRNA, protein, medicines, health, metabolites, digital-health, telehealth, therapeutic, well-being, transcriptomics, mental health, longevity, in vitro diagnostics, psychedelic, cannabis, pharmaceuticals, psychedelics, lifescience, bio, connected-health, cell therapy, biopharma, gene therapy, therapeutics, proteomics, molecules
- Invests in
- ["Canada","China","Switzerland","UK","USA"]
- Investment size
- max. $5M
- Founder groups
- Not publicly stated
Official source
TorontoStarts does not endorse or rank this record. Confirm current details with the official source.